JHS Svendgaard Laboratories Reports Mixed Performance in Q1 2024 Financial Results

JHS Svendgaard Laboratories, a microcap FMCG company, has recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Strong Sell' rating by MarketsMOJO.

According to the financial report, JHS Svendgaard Laboratories has shown a flat performance in the quarter, with a score of -5 which has improved from -11 in the last 3 months. However, there are some positive aspects to the company's financials.

The company's operating profit (PBDIT) for the quarter was the highest in the last five quarters at Rs 0.83 crore, indicating a positive trend in the near term. The operating profit margin for the quarter was also the highest in the last five quarters at 3.83%, showing an improvement in the company's efficiency.

On the other hand, there are some areas of concern for JHS Svendgaard Laboratories. The net sales for the half-yearly period have decreased by 29.28% year on year, indicating a negative trend in the near term. Similarly, the profit after tax (PAT) for the same period has also decreased by 29.28% year on year. Additionally, the company's non-operating income for the quarter is 761.11% of the profit before tax, which suggests that the company's income from non-business activities is high and may not be sustainable in the long run.

Overall, JHS Svendgaard Laboratories has shown a mixed performance in the quarter ending March 2024. While there are some positive aspects to the company's financials, there are also some areas of concern that investors should keep in mind.